RESUMO
PURPOSE: To assess temperament in patients with central serous chorioretinopathy (CSCR) compared to healthy controls. METHODS: A total of 32 patients diagnosed with acute CSCR and 30 healthy controls matched by age and sex were assessed with the self-report Cloninger's Temperament and Character Inventory. Central serous chorioretinopathy was diagnosed based on fluorescein angiography and spectral optical coherence tomography. RESULTS: Significantly higher mean scores of harm avoidance in patients with CSCR were found. Differences also were noted in subscales of novelty-seeking and reward dependence. CONCLUSIONS: The patients with CSCR demonstrated less exploratory behaviors, higher risk avoidance, restraint, and low extravagance. They were more quick-tempered, disorganized, and easily frustrated, with a tendency to avoid negative and potentially harmful stimuli, less tolerance to frustration, higher level of insecurity, and higher level of anticipatory anxiety.
Assuntos
Atitude Frente a Saúde , Coriorretinopatia Serosa Central/psicologia , Comportamentos Relacionados com a Saúde , Perfil de Impacto da Doença , Temperamento , Adulto , Estudos de Casos e Controles , Coriorretinopatia Serosa Central/diagnóstico , Feminino , Angiofluoresceinografia , Humanos , Masculino , Inventário de Personalidade/estatística & dados numéricos , Inquéritos e Questionários , Tomografia de Coerência ÓpticaRESUMO
PURPOSE: To assess differences in temperament in patients with central serous retinopathy and healthy subjects. MATERIAL AND METHODS: 20 patients diagnosed with acute central serous retinopathy was put to the questionnaire: Cloninger's Temperament and Character Inventory. RESULTS: Lower scores in novelty seeking (NS) (t = -2.43; p < 0.05) scale and its NS2 (t = -2.12; p < 0.05), and NS3 (t = -2.66; p < 0.05) subscales, as well as higher scores in harm avoidance HA4 subscale in CSR patients, were found. CONCLUSIONS: There is a different profile, regarding temperament and character in patients with central serous retinopathy, as compared to healthy subjects.